Clinical presentation of immune-mediated cerebellar ataxia

Revue Neurologique

Volumn 167, Issue 5, 2011, Pages 408-417

  Demarquay, G ^a   Honnorat, J ^a,b  

^a HÔPITAL NEUROLOGIQUE   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Cancer; Cerebellar ataxia; Onconeuronal antibodies; Paraneoplastic neurological syndromes

Indexed keywords

AUTOANTIBODY; CANCER ANTIBODY; CORTICOSTEROID; CV2 CRMP5 ANTIBODY; CYCLOPHOSPHAMIDE; ENDOMYSIUM ANTIBODY; GABAERGIC RECEPTOR AFFECTING AGENT; GLIADIN ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; HOMER 3 ANTIBODY; HU ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MGLUR1 ANTIBODY; OLIGOCLONAL BAND; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; PROTEIN KINASE C GAMMA ANTIBODY; RI ANTIBODY; RITUXIMAB; TR ANTIBODY; TRANSGLUTAMINASE 6 ANTIBODY; UNCLASSIFIED DRUG; VGCC ANTIBODY; YO ANTIBODY; ZIC ANTIBODY;

AGE DISTRIBUTION; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ATAXIA; AUTOIMMUNE DISEASE; BRAIN METASTASIS; BRAIN STEM INJURY; BREAST CANCER; CANCER CHEMOTHERAPY; CARCINOMATOUS MENINGITIS; CELIAC DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBELLAR ATAXIA; CEREBELLUM ATROPHY; CEREBROSPINAL FLUID ANALYSIS; CHOREA; CLINICAL FEATURE; COGNITIVE REHABILITATION; CORTICOSTEROID THERAPY; COUNSELING; CRANIAL NEUROPATHY; CROSS REACTION; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM FUNCTION DISORDER; DIPLOPIA; DISEASE ASSOCIATION; DISEASE COURSE; DIZZINESS; DYSARTHRIA; DYSAUTONOMIA; EATON LAMBERT SYNDROME; ENCEPHALITIS; ENDOMETRIUM CANCER; FLU LIKE SYNDROME; HASHIMOTO DISEASE; HEADACHE; HODGKIN DISEASE; HUMAN; IMMUNE MEDIATED INJURY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LUNG CANCER; LUNG SMALL CELL CANCER; MALABSORPTION; MUSCLE RIGIDITY; NAUSEA; NEOPLASM; NERVE CELL DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NEUROPATHOLOGY; NON PARANEOPLASTIC CEREBELLAR ATAXIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; ONSET AGE; OPSOCLONUS MYOCLONUS SYNDROME; OSCILLOPSIA; OVARY CANCER; OVARY CARCINOMA; PARANEOPLASTIC CEREBELLAR ATAXIA; PARANEOPLASTIC NEUROPATHY; PERIPHERAL NEUROPATHY; PLEOCYTOSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; RETINOPATHY; REVIEW; SENSORY NEUROPATHY; SEX RATIO; SJOEGREN SYNDROME; STIFF MAN SYNDROME; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMOMA; UTERINE CERVIX CANCER; UTERINE TUBE TUMOR; UTERUS SARCOMA; UVEITIS; VERTIGO;

CEREBELLAR ATAXIA; HUMANS; PARANEOPLASTIC SYNDROMES;

EID: 79957687437     PISSN: 00353787     EISSN: 00353787     Source Type: Journal    
DOI: 10.1016/j.neurol.2010.07.032     Document Type: Review

References (108)

1. Abele M, Weller M, Mescheriakov S, Bürk K, Dichgans J, Klockgether T. Cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Neurology 1999;52:857-9. (Pubitemid 29120198)
2. Abele M, Schöls L, Schwartz S, Klockgether T. Prevalence of antigliadin antibodies in ataxia patients. Neurology 2003;60:1674-5. (Pubitemid 36618099)
3. Albert ML, Darnell JC, Bender A, Franscisco LM, Bhardwaj N, Darnell RB. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nature Med 1998;11:1321-4. (Pubitemid 28512116)
4. Albert ML, Austin L, Darnell RB. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol 2000;47:9-17. (Pubitemid 30033645)
5. Almaguer-Mederos LE, Almira YR, Góngora EM, Gotay DA, Zaldivar YG, Pupo RE, et al. Antigliadin antibodies in Cuban patients with spinocerebellar ataxia type 2. J Neurol Neurosurg Psychiatry 2008;79:315-7. (Pubitemid 351303391)
6. Anderson NE, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration: clinical-immunological correlation. Ann Neurol 1988;24:559-67.
7. Antoine JC, Honnorat J, Koenig F, Aguera M, Belin MF, Michel D. Posterior uveitis and paraneoplastic encephalomyelitis with auto-antibodies reacting against cytoplasmic proteins of brain and retina. J Neurol Sci 1993;117:215-23. (Pubitemid 23274671)
8. Antoine JC, Absi L, Honnorat J, Boulesteix JM, De Brouker Th, Vial C, et al. Anti-amphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumours. Arch Neurol 1999;56:172-7. (Pubitemid 29076181)
9. Appenzeller S, Cendes F, Costallat LT. Cerebellar ataxia in systemic lupus erythematosus. Lupus 2008;17:1122-6.
10. Attwood W, Poser CM. Neurologic complications of Sjogren's syndrome. Neurology 1961;11:1034-41.
11. Bakchine S, Duyckaerts C, Hassine L, Chaunu MP, Turell E, Wechsler B, et al. Central and peripheral neurologic lesions in primary Gougerot-Sjögren syndrome. Clinicopathological study of a case. Rev Neurol 1991;147:368-75.
12. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990;347:151-6.
13. Balegno S, Ceroni M, Corato M, Franciotta D, Giometto B, Marinu-Aktipu K, et al. Antibodies to cerebellar nerve fibres in two patients with paraneoplastic cerebellar ataxia. Anticancer Res 2005;25:3211-4. (Pubitemid 41105191)
14. Bataller L, Wade DF, Graus F, Stacey HD, Rosenfeld MR, Dalmau J. Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology 2004;62:778-82. (Pubitemid 38298956)
15. Bataller L, Valero C, Díaz R, Froufe A, Garcia-Zarza A, Ribalta T, et al. Cerebellar ataxia associated with neuroendocrine thymic carcinoma and GAD antibodies. J Neurol Neurosurg Psychiatry 2009;80:696-7.
16. Bernal F, Shams'ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, et al. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology 2003;60:230-4.
17. Bonnan M, Cabre P, Olindo S, Signate A, Saint-Vil M, Smadja D. Steroid treatment in four cases of anti-GAD cerebellar ataxia. Rev Neurol 2008;164:427-33. (Pubitemid 351893087)
18. Boscolo S, Lorenzon A, Sblattero D, Florian F, Stebel M, Marzari R, et al. Antitransglutaminase antibodies cause ataxia in mice. PLoS One 2010;5:e9698.
19. Brain WR, Daniel PM, Greenfield JG. Subacute cortical cerebellar degeneration and its relation to carcinoma. J Neurol Neurosurg Psy 1951;14:59-75.
20. Brashear HR, Login IS, Mathe SA, Phillips LH. Cerebellar disorder in stiff-man syndrome [abstract]. Neurology 1997;48:A433.
21. Brieva-Ruíz L, Diaz-Hurtado M, Matias-Guiu X, Márquez- Medina D, Tarragona J, Graus F. Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study. Clin Neurol Neurosurg 2008;110:1044-6.
22. Brouwer B. Beitrag zur kenntnis der chronischen diffusen kleinhirnerkranghkungen. Neurol Centralbl 1919;38:674-82.
23. Bürk K, Melms A, Schulz JB, Dichgans J. Effectiveness of intravenous immunoglobin therapy in cerebellar ataxia associated with gluten sensitivity. Ann Neurol 2001;50:827-8. (Pubitemid 33116150)
24. Bushara KO, Goebel SU, Shill H, Goldfarb LG, Hallett M. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol 2001;49:540-3. (Pubitemid 32281342)
25. Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 2006;63:197-202. (Pubitemid 43261730)
26. Clouston PD, Saper CB, Arbizu T, Johnston I, Lang B, Newsom-Davis J, et al. Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology 1992;42:1944-50.
27. Collison K, Rees J. Asymmetric cerebellar ataxia and limbic encephalitis as a presenting feature of primary Sjögren's syndrome. J Neurol 2007;254:1609-11. (Pubitemid 350159907)
28. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu associated paraneoplastic encephalomyelitis/sensory neuropathy. Medicine 1992;71:59-72.
29. Dalmau JO, Gultekin SH, Voltz R, Hoard R, Deschamps T, Balmaceda C, et al. Ma1, a novel neuron-and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain 1999;122:27-39. (Pubitemid 29046270)
30. Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol 2008;7:327-40. (Pubitemid 351380534)
31. Darnell RB, Furneaux HM, Posner JB. Antiserum from a patient with cerebellar degeneration identifies a novel protein in Purkinje cells, cortical Neurons, and neuroectodermal tumors. J Neurosci 1991;11:1224-30.
32. de Andrés C, Esquivel A, de Villoria JG, Graus F, Sánchez-Ramón S. Unusual magnetic resonance imaging and cerebrospinal fluid findings in paraneoplastic cerebellar degeneration: a sequential study. J Neurol Neurosurg Psychiatry 2006;77:562-3.
33. De la Sayette V, Bertran F, Honnorat J, Schaeffer S, Iglesias S, Defer G. Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies: clinical response to excision of the primary tumor. Arch Neurol 1998;55:405-8. (Pubitemid 28146206)
34. Debes JD, Lagarde SM, Hulsenboom E, Sillevis Smitt PA, ten Kate FJ, Sulter GA, et al. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction. Dig Surg 2007;24:395-7.
35. Didelot A, Honnorat J. Update on paraneoplastic neurological syndromes. Curr Opin Oncol 2009;21:566-72.
36. Esposito M, Penza P, Orefice G, Pagano A, Parente E, Abbadessa A, et al. Successful treatment of paraneoplastic cerebellar degeneration with Rituximab. J Neurooncol 2008;86:363-4.
37. Felician O, Renard JL, Vega F, Créange A, Chen QM, Bequet D, et al. Paraneoplastic cerebellar degeneration with anti-Yo antibody in man. Neurology 1995;45:1226-7.
38. Fritzler MJ, Kerfoot SM, Feasby TE, Zochodone DW, Westendorf JM, Dalmau JO, et al. Autoantibodies from patients with idiopathic ataxia bind to M-phase phosphoprotein-1 (MPP1). J invest Med 2000;48:28-39. (Pubitemid 30485619)
39. Gahring LC, Rogers SW, Twyman RE. Autoantibodies to glutamate receptor subunit GluR2 in non-familial olivopontocerebellar degeneration. Neurology 1997;48:494-500. (Pubitemid 27087627)
40. Gilmore CP, Elliott I, Auer D, Maddison P. Diffuse cerebellar MR imaging changes in anti-Yo positive paraneoplastic cerebellar degeneration. J Neurol 2010;257:490-1.
41. Giometto B, Miotto D, Faresin F, Argentiero V, Scaravilli T, Tavolato B. Anti-GABAergic neuron autoantibodies in a patient with stiff-man syndrome and ataxia. J Neurol Sci 1996;143:57-9. (Pubitemid 26402786)
42. Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G, et al. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol 2010;67:330-5.
43. Gottfried JA, Finkel TH, Hunter JV, Carpentieri DF, Finkel RS. Central nervous system Sjögren's syndrome in a child: case report and review of the literature. J Child Neurol 2001;16:683-5. (Pubitemid 32976391)
44. Graus F, Cordon-Cardo C, Posner JB. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 1985;35:538-43. (Pubitemid 15085073)
45. Graus F, Dalmau J, Valldeoriola F, Ferrer I, René R, Marin C, et al. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. J Neuroimmunol 1997;74:55-61. (Pubitemid 27128977)
46. Graus F, Lang B, Pozo-Rosich P, Saiz A, Casamitjana R, Vincent A. P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 2002;59:764-6.
47. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-40. (Pubitemid 39005770)
48. Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 2010;257:509-17.
49. Greenlee JE, Brashear HR. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol 1983;14:609-13. (Pubitemid 14211606)
50. Hadjivassiliou M, Grünewald RA, Chattopadhyay AK, Davies-Jones GAB, Gibson A, Jarratt JA, et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet 1998;352:1582-5. (Pubitemid 28515242)
51. Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol 2008;64:332-43.
52. Hammack J, Kotanides H, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease. Neurology 1992;42:1938-43.
53. Honnorat J, Trouillas P, Thivolet C, Aguera M, Belin MF. Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements. Arch Neurol 1995;52:462-8.
54. Honnorat J, Antoine JC, Derrington E, Aguera M, Belin MF. Antibodies to a subpopulation of glial cells and a 66-kD developmental protein in patients with paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatr 1996;61:270-8. (Pubitemid 26293722)
55. Honnorat J, Guillon B, De Ferron E, Aguera M, Antoine JC, Dalmau J. Association of antineural autoantibodies in a patient with paraneoplastic cerebellar syndrome and small cell lung carcinoma. J Neurol Neurosurg Psy 1997;62:425-6. (Pubitemid 27199130)
56. Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, et al. Cerebellar ataxia with antiglutamic acid decarboxylase antibodies: clinical and immunological data of a series of 14 patients. Arch Neurol 2001;58:225-30. (Pubitemid 32163159)
57. Honnorat J, Cartalat-Carel S, Ricard D, et al. Onconeural antibodies and tumour type determine survival and neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosug Psychiatry 2009;80:412-6.
58. Ikeda J, Harada T, Kamei H, Nakamura S. Autoantibody to glutamate decarboxylase in a patient with spinocerebellar degeneration and Sjögren syndrome. No To Shinkei 1998;50:177-80. (Pubitemid 28136361)
59. Ishida K, Mitoma H, Song SY, Uchihara T, Inaba A, Eguchi S, et al. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol 1999;46:263-7. (Pubitemid 29382886)
60. Ito H, Sayama S, Irie S, Kanazawa N, Saito T, Kowa H, et al. Antineuronal antibodies in acute cerebellar ataxia following Epstein-Barr virus infection. Neurology 1994;44:1506-7. (Pubitemid 24247446)
61. Kikuchi H, Yamada T, Okayama A, Hara H, Taniwaki T, Shigeto H, et al. Anti-Ri-associated paraneoplastic cerebellar degeneration without opsoclonus in a patient with a neuroendocrine carcinoma of the stomach. Fukuoka Igaku Zasshi 2000;91:104-9.
62. Krakauer J, Balmaceda C, Gluck JT, Posner JB, Fetell MR, Dalmau J. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of unknown origin. Neurology 1996;46:1486-7. (Pubitemid 26164653)
63. Krief P, Silver A, Eberhard A, Maytal J. Fifteen-year-old girl with systemic lupus erythematosus and unilateral cerebellitis. Lupus 2010;19:981-4[Epub ahead of print].
64. Krolak-Salmon P, Androdias G, Meyronet D, Aguera M, Honnorat J, Vighetto A. Slow evolution of cerebellar degeneration and chorea in a man with anti-Yo antibodies. Eur J Neurol 2006;13:307-8.
65. Lauria G, Pareyson D, Pitzolu MG, Bazzigaluppi E. Excellent response to steroid treatment in anti-GAD cerebellar ataxia. Lancet Neurol 2003;2:634-5. (Pubitemid 37162573)
66. Lennon VA, Kryzer TJ, Griesmann GE, O'Suilleabhain PE, Windebank AJ, Woppmann A, et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467-74.
67. Luque FA, Furneaux HM, Ferziger R, Rosenblum MK, Wray SH, Schold SC, et al. Anti-Ri: an autoantibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 1991;29:241-51.
68. Malamud N. In: Berkeley CA, editor. Atlas of neuropathology. San Franscisco: University of California Press; 1957. p. 118.
69. Manto MU, Laute MA, Aguera M, Rogemond V, Pandolfo M, Honnorat J. Effects of antiglutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol 2007;61:544-51. (Pubitemid 47068136)
70. Manto MU, Rondeaux P, Jacquy J, Hildebrand JG. Subacute pancerebellar syndrome associated with systemic lupus erythematosus. Clin Neurol Neurosurg 1996a;98:157-60. (Pubitemid 26245456)
71. Manto M, Goldman S, Bodur H. Cerebellar syndrome associated with Hashimoto's encephalopathy. Rev Neurol 1996b;152:202-4. (Pubitemid 26146821)
72. Marignier R, Chenevier F, Rogemond V, Sillevis Smitt P, Renoux C, Cavillon G, et al. Metabotropic glutamate receptor type 1 autoantibody- associated cerebellitis: a primary autoimmune disease? Arch Neurol 2010;67:627-30.
73. Mason WP, Graus F, Lang B, Honnorat J, Delattre JY, Vallderiola F, et al. Paraneoplastic cerebellar degeneration and small cell lung cancer. Brain 1997;120:1279-300.
74. McFarland NR, Login IS, Vernon S, Burns TM. Improvement with corticosteroids and azathioprine in GAD65-associated cerebellar ataxia. Neurology 2006;67:1308-9.
75. McHugh JC, Tubridy N, Collins CD, Hutchinson M. Unusual MRI abnormalities in anti-Yo positive "pure" paraneoplastic cerebellar degeneration. J Neurol 2008;255:138-9.
76. Meglic B, Graus F, Grad A. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma. J Neurol Sci 2001;185:135-8. (Pubitemid 32318519)
77. Motomura M, Lang B, Johnston I, Palace J, Vincent A, Newsom-Davis J. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci 1997;147:35-42. (Pubitemid 27117502)
78. Mouzak A, Agathos P, Vourdeli-Giannakoura E. Subacute cerebellar syndrome and Hashimoto's thyroiditis. Association or simple coincidence? Acta Neurol Scand 2002;106:374-8.
79. Owada K, Uchihara T, Ishida K, Mizusawa H, Watabiki S, Tsuchiya K. Motor weakness and cerebellar ataxia in Sjögren syndrome - identification of antineuronal antibody: a case report. J Neurol Sci 2002;197:79-84. (Pubitemid 34462149)
80. Pellecchia MT, Scala R, Filla A, De Michele G, Ciacci C, Barone P. Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J Neurol Neurosurg Psychiatry 1999;66:32-5. (Pubitemid 29101483)
81. Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 1992;42:1931-7.
82. Phuphanich S, Brock C. Neurologic improvement after highdose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody. J Neurooncol 2007;81:67-9. (Pubitemid 44963991)
83. Rakocevic G, Raju R, Semino-Mora C, Dalakas MC. Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies. Neurology 2006;67:1068-70. (Pubitemid 44454608)
84. Rogemond V, Honnorat J. Anti-CV2 autoantibodies and paraneoplastic neurological syndromes. Clin Rev All Immunol 2000;19:48-57.
85. Rojas I, Graus F, Keime-Guibert F, René R, Delattre JY, Ramon JM, et al. Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 2000;55:713-5.
86. Sabater L, Bataller L, Carpentier AF, Aguirre-Cruz ML, Saiz A, Benyahia B, et al. Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer. J Neurol Neurosurg Psychiatry 2006;77:1359-62. (Pubitemid 44851996)
87. Sabater L, Bataller L, Suárez-Calvet M, Saiz A, Dalmau J, Graus F. ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer. J Neuroimmunol 2008;201-202:163-5.
88. Saiz A, Arpa J, Sagasta A, Casamitjana R, Zarranz JJ, Tolosa E, et al. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin dependent, and polyendocrine autoimmunity. Neurology 1997;49:1026-30.
89. Saiz A, Blanco Y, Sabater L, González F, Bataller L, Casamitjana R, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008;131:2553-63.
90. Selim M, Drachman DA. Ataxia associated with Hashimoto's disease: progressive non-familial adult onset cerebellar degeneration with autoimmune thyroiditis. J Neurol Neurosurg Psychiatry 2001;71:81-7.
91. Shams'ili S, Grefkens J, de Leeuw B, van den Bent M, Hooijkaas H, van der Holt B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 2003;126:1409-18.
92. Sillevis-Smitt P, Kinoshita A, De Leeuw B, Moll W, Coesmans M, Jaarsma D, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. New Engl J Med 2000;342:21-7. (Pubitemid 30020656)
93. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 1990;322:1555-60. (Pubitemid 20176695)
94. Solimena M, De Camilli P. Autoimmunity to glutamic acid decarboxylase (GAD) in stiff-man syndrome and insulin-dependent diabetes mellitus. Trends Neurosci 1991;14:452-7.
95. Sutton IJ, Fursdon Davis CJ, Esiri MM, Hughes S, Amyes ER, Vincent A. Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus. Ann Neurol 2001;49:253-7. (Pubitemid 32158003)
96. Tanaka K, Yamazaki M, Sata S, Toyoshima I, Yamamoto A, Miyatake T. Antibodies to brain proteins in paraneoplastic cerebellar degeneration. Neurology 1986;36:1169-72. (Pubitemid 16046992)
97. Terao Y, Sakai K, Kato S, Tanabe H, Ishida K, Tsukamoto T. Antineuronal antibody in Sjögren's syndrome masquerading as paraneoplastic cerebellar degeneration. Lancet 1994;343:790. (Pubitemid 24098703)
98. Thöne J, Hohaus A, Lamprecht S, Bickel A, Erbguth F. Effective immunosuppressant therapy with cyclophosphamide and corticosteroids in paraneoplastic cerebellar degeneration. J Neurol Sci 2008;272:171-3.
99. Tilikete C, Vighetto A, Trouillas P, Honnorat J. Anti-GAD antibodies and periodic alternating nystagmus. Arch Neurol 2005;62:1300-3. (Pubitemid 41168360)
100. Vulliemoz S, Vanini G, Truffert A, Chizzolini C, Seeck M. Epilepsy and cerebellar ataxia associated with antiglutamic acid decarboxylase antibodies. J Neurol Neurosurg Psychiatry 2007;78:187-9. (Pubitemid 46220220)
101. Voltz RD, Posner JB, Dalmau J, Graus F. Paraneoplastic encephalomyelitis: an update of the effects of the anti-Hu immune response on the nervous system and tumour. J Neurol Neurosurg Psychiatry 1997;63:133-6. (Pubitemid 27388957)
102. Walikonis JE, Lennon VA. Radio-immunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Mayo Clin Proc 1998;73:1161-6. (Pubitemid 28560164)
103. Wong S, Pollock AN, Burnham JM, Sherry DD, Dlugos DJ. Acute cerebellar ataxia due to Sjögren syndrome. Neurology 2004;62:2332-3. (Pubitemid 38787808)
104. Xia K, Saltzman JR, Carr-Locke DL. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma. Med Gen Med 2003;5:18.
105. Yaginuma M, Suenaga M, Shiono Y, Sakamoto M. Acute cerebellar ataxia of a patient with SLE. Clin Neurol Neurosurg 2000;102:37-9. (Pubitemid 30136484)
106. Yoshimoto T, Doi M, Fukai N, Izumiyama H, Wago T, Minami I, et al. Type 1 diabetes mellitus and drug-resistant epilepsy: presence of high titer of antiglutamic acid decarboxylase autoantibodies in serum and cerebrospinal fluid. Intern Med 2005;44:1174-7.
107. Yoon JW, Yoon CS, Lim HW, Huang QQ, Kang Y, Pyun KH, et al. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science 1999;284:1183-7. (Pubitemid 29288411)
108. Zuliani L, Sabater L, Saiz A, Baiges JJ, Giometto B, Graus F. Homer 3 autoimmunity in subacute idiopathic cerebellar ataxia. Neurology 2007;68:239-40. (Pubitemid 46105747)